Literature DB >> 15893355

Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine.

Juan M Pacheco1, Mario C S Brum, Mauro P Moraes, William T Golde, Marvin J Grubman.   

Abstract

We have previously demonstrated that swine vaccinated with one dose of a replication-defective human adenovirus type 5 (Ad5) vector containing the capsid and 3C proteinase coding regions of foot-and-mouth disease virus (FMDV) were protected when challenged 7 days later with homologous virus. In the current study, we have extended this approach to cattle, the most economically important animals susceptible to FMD. Five cattle were vaccinated with the Ad5-FMDV subunit vaccine and these animals and 2 co-housed control animals were challenged intradermolingually 7 days later. Both control animals developed typical signs of FMD including fever and vesicular lesions on all 4 feet. All 5 vaccinated animals were protected against disseminated disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15893355     DOI: 10.1016/j.virol.2005.04.014

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  33 in total

1.  Immunogenicity and efficacy of a recombinant adenovirus expressing hemagglutinin from the H5N1 subtype of swine influenza virus in mice.

Authors:  Yunpu Wu; Chuanling Qiao; Huanliang Yang; Yan Chen; Xiaoguang Xin; Hualan Chen
Journal:  Can J Vet Res       Date:  2014-04       Impact factor: 1.310

2.  Modelling dynamics of the type I interferon response to in vitro viral infection.

Authors:  Tom J Howat; Cristina Barreca; Peter O'Hare; Julia R Gog; Bryan T Grenfell
Journal:  J R Soc Interface       Date:  2006-10-22       Impact factor: 4.118

3.  Differential effects of viral vectors on migratory afferent lymph dendritic cells in vitro predict enhanced immunogenicity in vivo.

Authors:  C Cubillos-Zapata; E Guzman; A Turner; S C Gilbert; H Prentice; J C Hope; B Charleston
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

Review 4.  Viruses as vaccine vectors for infectious diseases and cancer.

Authors:  Simon J Draper; Jonathan L Heeney
Journal:  Nat Rev Microbiol       Date:  2010-01       Impact factor: 60.633

5.  Induction of foot-and-mouth disease virus-specific cytotoxic T cell killing by vaccination.

Authors:  Jared R Patch; Lasse E Pedersen; Felix N Toka; Mauro Moraes; Marvin J Grubman; Morten Nielsen; Gregers Jungersen; Soren Buus; William T Golde
Journal:  Clin Vaccine Immunol       Date:  2010-12-22

6.  Characterization of cytotoxic T lymphocyte function after foot-and-mouth disease virus infection and vaccination.

Authors:  Jared R Patch; Mary Kenney; Juan M Pacheco; Marvin J Grubman; William T Golde
Journal:  Viral Immunol       Date:  2013-07-05       Impact factor: 2.257

7.  Interferon-induced protection against foot-and-mouth disease virus infection correlates with enhanced tissue-specific innate immune cell infiltration and interferon-stimulated gene expression.

Authors:  Fayna Diaz-San Segundo; Mauro P Moraes; Teresa de Los Santos; Camila C A Dias; Marvin J Grubman
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

8.  Attenuated foot-and-mouth disease virus RNA carrying a deletion in the 3' noncoding region can elicit immunity in swine.

Authors:  Miguel Rodríguez Pulido; Francisco Sobrino; Belén Borrego; Margarita Sáiz
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

9.  Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons.

Authors:  Mauro Pires Moraes; Teresa de Los Santos; Marla Koster; Traci Turecek; He Wang; Vladimir G Andreyev; Marvin J Grubman
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

10.  Expression of porcine fusion protein IRF7/3(5D) efficiently controls foot-and-mouth disease virus replication.

Authors:  Lisbeth Ramírez-Carvajal; Fayna Díaz-San Segundo; Danielle Hickman; Charles R Long; James Zhu; Luis L Rodríguez; Teresa de los Santos
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.